Lexaria enters manufacturing and license agreements with BevNology for DehydraTECH CBD tech

Lexaria Bioscience Corp.

Manufacturing operating agreement for fee-based production of DehydraTECH-enabled APIs for corporate clients.
Five-year global non-exclusive license for hemp CBD (<0.3% THC) in bulk powders, liquids, and finished consumer products.
Exclusions: Japan, South Korea, China; limited exclusive US rights for bulk liquids subject to minimum fee.
No financial terms disclosed; agreements described as non-material.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.